We are live on ! Find out more
RPTX

Repare Therapeutics
RPTX

Delisted

RPTX was delisted on the 27th of January, 2026.

Back to rankings

48 hedge funds and large institutions have $709M invested in Repare Therapeutics in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

65.73% more ownership

Funds ownership: 0% → 65.73% (+66%)

Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
0.98%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.1%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$110M
2
MAM
MPM Asset Management
Massachusetts
+$96.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$81.1M
4
CA
CHI Advisors
New York
+$80.4M
5
MB
MPM BioImpact
Massachusetts
+$76.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$1.21M +$1.25M +38,960 New
Tudor Investment Corp
27
Tudor Investment Corp
Connecticut
$1.05M +$1.09M +33,913 New
Blackstone Inc
28
Blackstone Inc
New York
$931K +$963K +30,000 New
PCM
29
Pinz Capital Management
New York
$924K +$957K +29,800 New
MWNA
30
Marshall Wace North America
New York
$902K +$934K +29,087 New
Jane Street
31
Jane Street
New York
$780K +$807K +25,139 New
CM
32
Crestline Management
Texas
$779K +$806K +25,101 New
Citadel Advisors
33
Citadel Advisors
Florida
$700K +$724K +22,565 New
Geode Capital Management
34
Geode Capital Management
Massachusetts
$663K +$687K +21,402 New
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$465K +$482K +15,000 New
PCM
36
Pentwater Capital Management
Florida
$419K +$433K +13,500 New
Morgan Stanley
37
Morgan Stanley
New York
$385K +$399K +12,421 New
Goldman Sachs
38
Goldman Sachs
New York
$383K +$397K +12,353 New
GGHC
39
Gilder Gagnon Howe & Co
New York
$115K +$119K +3,711 New
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$62K +$64.2K +2,000 New
TRCT
41
Tower Research Capital (TRC)
New York
$27K +$28K +873 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$27K +$32.8K +1,022 New
Legal & General Group
43
Legal & General Group
United Kingdom
$16K +$16.1K +500 New
FIA
44
FNY Investment Advisers
New York
$9K +$9.63K +300 New
US Bancorp
45
US Bancorp
Minnesota
$6K +$6.42K +200 New
Carson Wealth (CWM LLC)
46
Carson Wealth (CWM LLC)
Nebraska
$3K +$3.21K +100 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$3K +$3.21K +100 New
FAM
48
Fred Alger Management
New York
$1K +$1.25K +39 New
1
2

RPTX Hedge Fund Activity: Q2 2020 in Review

48 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q2 2020, worth a combined $709M.

Buyers outnumbered sellers: 48 funds opened new RPTX positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $110M.

  • 48 institutional investors held Repare Therapeutics (RPTX) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $709M of Repare Therapeutics stock for Q2 2020.
  • 48 funds opened new Repare Therapeutics positions in Q2 2020 and 0 closed out, a net change of +48 holders.
  • The largest Repare Therapeutics buyer in Q2 2020 was OrbiMed, an estimated $110M added.

Based on aggregated 13F filings for Q2 2020.